Objective: Many studies have described constructing a prediction model for bacteremia in community-acquired pneumonia (CAP), but these studies were not validated in external heterogeneous groups. The objective of this study was to test the generalizability of a previous bacteremia prediction model for CAP by external validation.
I n infectious disease, the isolation of causative pathogens and antibiotic susceptibility tests of those pathogens are basic steps in patient treatment strategies. Traditionally, blood culture is one of many methods to identify the etiology of an infection. In community-acquired pneumonia (CAP), the yield of the blood cultures is low, and approximately 5% to 14% of blood cultures from hospitalized patients were found to be positive in previous studies. 1, 2 Many previous studies reported that the performance of blood cultures has very limited utility and a low chance of affecting patient care for immunocompetent patients. [3] [4] [5] In addition to the low yield and limited clinical utility, false-positive blood cultures could cause prolonged hospital stays, which lead to increased costs. 6, 7 From the patient's point of view, additional phlebotomy for blood cultures is unwelcome. Additionally, in most crowded emergency departments (ED), performing blood cultures is time-consuming and utilizes resources. 8 Even though many previous studies have proven the limited utility of blood cultures, the collection of blood cultures from patients hospitalized with CAP continues to increase. 9 The Infectious Diseases Society of America/American Thoracic Society guidelines suggest performing blood cultures in certain groups of patients who have multiple risk factors for bacteremia, which leaves the decision to perform blood cultures for other patients at the discretion of the physician. 10 To support a reduction in the number of blood cultures in patients who have a low risk of bacteremia, there have been several studies in which bacteremia prediction models have been derived using patients' vital signs, medical history, and laboratory findings. [11] [12] [13] However, a common limitation of those studies is that the generalizability of the derived models was not tested by external validation in more heterogeneous groups. Although our preceding study validated a derived model in another independent tertiary academic hospital, it is insufficient to apply the model to common CAP patients. 12 Therefore, a more definitive study should be performed to reduce the number of unnecessary blood cultures in the ED, and the results could support the omission of blood cultures for certain patients.
In this study, we performed external validation of the preceding bacteremia prediction model in eight tertiary academic hospitals. In addition to testing the generalizability of the model, we presented important predictors of bacteremia by constructing new models with various variables and comparing them with the preceding model.
METHODS

Study Design and Setting
This study is a multicenter retrospective observational study based on eight tertiary urban hospitals. All the hospitals are located at the city of Seoul, the population of which is 10 million people. During the study periods, the annual ED census of those hospitals ranged from 51,630 to 109,559 patients (Data Supplement S1, Table S1 , available as supporting information in the online version of this paper, which is available at https://doi.org/onlinelibrary.wiley.c om/doi/10.1111/acem.13255/full). Study subjects were identified by electronic medical record (EMR) query language based on diagnostic codes of the International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) indicating pneumonia. An experienced research coordinator extracted all the clinical information from a relational database that underlies the EMR of the eight hospitals. Data collection and analysis were approved by the institutional review board of each studied hospital.
Selection of Participants
The eligible patients were individuals who were older than 18 years of age with a diagnosis of CAP and admitted to the respective hospital associated with the ED where blood cultures were performed between January 1, 2014, and December 31, 2014. The patients who were discharged from the ED, transferred to other hospitals, or diagnosed with hospital-acquired pneumonia (HAP) or health care-associated pneumonia (HCAP) were excluded. HAP is defined as pneumonia that occurs 48 hours or more after hospitalization. Patients who were treated in a hospital, nursing home, or long-term care facility for 2 or more days within 90 days of the infection were classified as having HCAP. 14, 15 Finally, patients with ventilatorassociated pneumonia (VAP), which is defined as pneumonia that develops more than 48 to 72 hours after endotracheal intubation, were excluded.
Two authors (BK and JC) reviewed all extracted clinical information independently and selected eligible patients based on the inclusion and exclusion criteria described. The inter-rater agreement between the two authors was calculated using the kappa statistic, and any discrepancies between the authors were resolved through consensus. Epidemiologic factors, such as age, sex, height and weight, and a past medical history, including diabetes, hypertension, chronic liver disease, renal dysfunction, asthma or chronic obstructive pulmonary disease, history of tuberculosis, neoplasm, and prior antibiotic use, were reviewed. Vital signs, including systolic blood pressure, body temperature, heart rate, and respiratory rate (RR), were reviewed. Additionally, laboratory test results upon initial ED presentation, such as white blood cell count, hematocrit, platelet count, albumin, C-reactive protein (CRP), blood urea nitrogen (BUN), creatinine, sodium (Na), and glucose, were reviewed independently by the authors. After an independent review was conducted by the authors, consensus was reached regarding discrepancies. The following isolates were identified as contaminants: coagulase-negative Staphylococcus, Bacillus sp., Micrococcus sp., Corynebacterium sp., and Propionibacterium sp.
Outcome Measures
The primary outcomes were the number of patients with or without blood culture-positive results stratified by the risk predicted by the previous bacteremia prediction model (see Table 1 for a detailed criteria of the model). In a previous study, we derived the scoring system based on variables described above to predict the likelihood of bacteremia. All points for the seven factors were summed and stratified to the following three levels of risk: low(<5), moderate (6) (7) (8) (9) (10) , and high (>11). 12 We identified significant predictors associated with bacteremia using univariable and multivariable analysis and compared them with those of the previous model.
Data Analysis
Continuous variables are presented as the means and standard deviations (SDs). Binomial variables are presented as the frequency of occurrence and were compared with the chi-square test. Categorical variables, mainly bacteremia risk and blood culture results, are tabulated and analyzed using Fisher's exact test. A comparison between the bacteremia-positive group and the other groups was performed using the Wilcoxon rank sum test. The receiver operating characteristic (ROC) curve was drawn, and the area under the curve (AUC) was calculated and compared with that of the previous study to evaluate the discrimination capability of the prediction model.
To identify the most significant factors for bacteremia prediction, multivariable analysis was performed using the candidate variable with a factor significance of p < 0.05 in the univariable analysis. Variables were removed from the multivariable model in a stepwise manner by backward elimination. The ROC curve and the AUC were compared between each logistic model using various factors. To identify the risk of overfitting and model simplicity, the Bayesian information criterion (BIC) for each model was calculated. BIC is a criterion for model selection that penalizes the number of variables to avoid overfitting. A model is better than another if it has a smaller BIC value. 16 Finally, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio, and negative likelihood ratio were calculated for each model. Sensitivity and specificity were compared using McNemar's test. The PPV and NPV were compared using relative predictive values. 17 Also, the positive likelihood ratio and negative likelihood ratio differences were compared using regression models. 18 All analyses were performed using STATA (version 13, StataCorp) and R (version 3.3.3, R Foundation for Statistical Computing).
RESULTS
Characteristics of Study Subjects
A total of 3,940 patients were identified by diagnostic codes of ICD-9-CM. Of these patients, 1,830 patients BT = body temperature; CRP = C-reactive protein; HR = heart rate; sBP = systolic blood pressure; WBC = white blood cell.
were excluded because the authors' consensus concluded that these patients were classified as having HAP, HCAP, or VAP. The initial kappa statistic between the two authors was 0.98, and discrepancies between the authors were resolved through consensus. From the remaining 2,110 patients, 109 patients were excluded because blood cultures were not performed ( Figure 1 ). The baseline demographic findings, vital signs, and laboratory tests of the validation cohort were compared with the previous internal validation cohort (Table 2) . Additionally, baseline characteristics of the enrolled patients from each hospital were compared (Table S1 ). The mean age of the validation cohort was 67.5, and 1,228 (61.4%) of the enrolled patients were males. Among a total of 115 culture-positive cases, 57 culturepositive results (2.8%, 95% confidence interval [CI] = 2.1%-3.7%) were true pathogens, and the other 58 results were considered to be contaminants. Escherichia coli was the most frequently grown organism, followed by Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae (Table S2) . Table 3 shows the number and proportion of the patients' corresponding culture results stratified into three groups. Similar to the previous study, 79.6% of patients were identified as the low-risk group, of which only 1.2% of the patients had a positive culture. The risks were 7.3 and 31.5% in the moderate-and highrisk groups, respectively. Figure 2 shows the ROC and the AUC of the prediction model compared with that of the previous study. The AUC was 0.81 (95% CI = 0.75-0.83), and there was no significant difference between the internal and external validation cohorts (p = 0.246).
External Validation of the Previous Bacteremia Prediction Rule
Identification of Significant Predictors for Bacteremia in the External Validation Cohort
Univariable analysis was performed to compare the bacteremia-positive and bacteremia-negative groups (Table S3 ). After multivariable analysis using statistically significant variables by stepwise backward elimination, the following six variables were identified as useful predictive factors for bacteremia in CAP: a platelet count less than 130 9 10 9 cells/L, albumin less than 3.3 mg/dL, CRP greater than 17 mg/dL, RR greater than 30 cycles per minute, Na less than 130 mg/dL, and BUN greater than 30 mg/dL (Table 4) . Among the six variables, three factors, namely, platelet count, albumin, and CRP overlapped with the seven variables of the previous study (Table 1) . Using those six variables and three factors, calculated AUCs of the logistic model were 0.84 (95% CI = 0.78-0.89) and 0.82 (95% CI = 0.77-0.88), respectively (Table S4) . There was no statistically significant difference between the AUCs of the two models (p = 0.39). The BIC for the model that used only three variables was 456, which was the lowest value among the models (Table S4) . 
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Discrimination Power of the Three Predictors (Simplified Model)
The number of patients with true bacteremia stratified by the presence of three predictors was compared with the previous prediction model (Table S5 ). If we did not perform blood cultures on the patient group in which none or one of the three predictors was present, 81% of the patients were in the blood cultureunnecessary group of which blood culture yield was Data are reported as mean AE SD or n (%). CRP = C-reactive protein; COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; WBC = white blood cell; BUN = blood urea nitrogen. *Data from previous study. 1% (95% CI = 0.6%-1.7%). The sensitivity and specificity of the simplified model were 0.70 (95% CI = 0.56-0.81) and 0.83 (95% CI = 0.81-0.84), respectively; the specificity was significantly higher than that of the previous prediction model (p = 0.015; Table 5 ).
DISCUSSION
Using a previously developed bacteremia risk prediction model from CAP patients, we performed external validation of the model in the general population from eight tertiary urban hospitals. In terms of baseline characteristics, this study included younger and fewer male patients than the previous study (Table 2) . Additionally, the true bacteremia rate (2.8%) was less than that of the previous study (5.3%). Although the baseline characteristics were somewhat different from the original cohort, the AUC was still higher than that of the internal validation cohort without statistically significant differences. The model seems to be well fitted to the more expanded population. The application of the prediction model could potentially eliminate the need for obtaining a blood culture in 80% of patients, i.e., in the low-risk group. If blood culture is not performed in the low-risk group, the costs that patients should pay for blood culture decreased from $47.40 (95% CI = $46.90-$47.90) to $18.8 (95% CI = $17.70-$19.80). Also, considering the time-consuming aseptic procedure involved in performing the blood culture and the low chance of affecting patient management, blood culture in low-risk patients could be omitted.
Without blood culture, there could be concerns to miss the isolation of true pathogens and, subsequently, to change to appropriate antibiotics, but it has been well known that bacteremia in pneumococcal CAP was not associated with clinical outcomes. [19] [20] [21] In our results the presence of bacteremia was not associated with 30-day mortality (odds ratio [OR] = 1.39, 95% CI = 0.64-3.05, p = 0.416). Also contamination rate of blood culture performed in the low-risk group was 2.9% (46/1,592) which was higher than that of true bacteremia (Table 3 ). In one previous study, there was 20% of additional unnecessary glycopeptide treatment due to blood culture contamination. 22 In our study the unnecessary use of glycopeptide antibiotics such as vancomycin was 0.9% (15/1,592), which was higher than 0.3% (4/1,592) of proper antibiotics changes by blood culture results in the low-risk group.
To identify significant predictors for bacteremia in the external validation cohort, we performed a multivariable analysis and compared the variables in the analysis with those of the previous study. To construct more sophisticated prediction models using many parameters is important, but it is also important to identify few significant predictors that have clinical validity. For easy implementation of clinical prediction rules, the prediction rules should be user friendly and simple to remember. 23 Using a calculator to add the coefficient of various parameters would result in less LR(+) = positive likelihood ratio; LR(-) = negative likelihood ratio; NPV = negative predictive value; PPV = positive predictive value. *Previous model using seven variables: systolic blood pressure < 90 mmHg, heart rate > 125 beats/min, body temperature < 35 or > 40°C, white blood cell < 4 9 10 9 or > 12 9 10 9 cells/L, platelets < 130 9 10 9 cells/L, albumin < 3.3 g/dL, CRP > 17 mg/dL. †Simplified model using only three variables: platelets < 130 9 10 9 cells/L, albumin < 3. use of the prediction rule for blood culture reduction. 24 For balance between discrimination power and simplicity of use, we simultaneously calculated the AUC and BIC of the different models using various variables (Table S4) . Satisfying the presence of only three predictors could rule out more than four-fifths of patients for whom the blood culture has little value.
In addition to the simplicity of the model, clinical validity of variables in the model is important for the wide implementation of the model. 23 In this respect, the clinical meaning of the three predictors, which overlap with the previous rule, should be mentioned. Platelet counts less than 130 9 10 9 cells/L, that is, thrombocytopenia, have been known to be associated with the incidence of bacteremia in critically ill patients with severe sepsis and septic shock. 25 Thrombocytopenia has also been known to be a prognostic marker in sepsis with bacteremia. 26, 27 Similarly, an albumin level less than 3.3 mg/dL, that is, hypoalbuminemia, is highly associated with recurrent bacteremia in patients with renal replacement therapy and is a risk factor for mortality in patients with chronic renal failure and bacteremia. 28, 29 Thrombocytopenia and hypoalbuminemia may be clinically indicative of liver diseases, and the presence of liver diseases has been included in the bacteremia prediction model in several studies. 6, 11 The last of the three predictors was CRP greater than 17 mg/dL. High CRP alone was not considered a sole indicator of bacteremia in CAP, but it could be a useful marker for antibiotic treatment failure in CAP. 30, 31 Daily CRP measurements could be useful, especially for severe CAP patients in whom a change in antibiotic therapy according to the isolated pathogen is critical. 32 Therefore, if high CRP is included in the clinical decision-making rule for blood culture, there can be a better chance for the blood culture to affect clinical outcomes, especially in severely ill patients.
In this study, the most common pathogen proven by blood culture was E. coli followed by S. aureus, S. pneumoniae, and K. pneumoniae. CAP caused by E. coli is frequently blood culture positive and is generally more likely to be associated with severe illness than other pathogens. 33 The study population was from tertiary urban hospitals. There might be a chance of selection bias because many of the local hospitals transfer unexpectedly severely ill CAP patients to tertiary hospitals. Additionally, not only CAP but also other coinfections, such as acute pyelonephritis or acute cholangitis, might be included because acute respiratory symptoms and acute lung injury can be present in severe sepsis from a nonpulmonary source. 34, 35 
LIMITATIONS
Our study has several limitations. The culture-positive rate of 2.8% in this study is somewhat lower than historical counterparts, which ranged from 5% to 14%. 1, 2 All our data came from tertiary hospitals, in which most patients were referred from other hospitals. In patients with fever who were prescribed antibiotics prior to the ED presentation, the antibiotics were not sufficient to cure the pneumonia but were just effective enough to decrease the chance of a positive culture study. This may be considered as a possible confounder to the study; however, we did not exclude from the analysis patients who were prescribed antibiotics prior to the ED visit. In fact, 19.1% of patients were taking antibiotics prior to the ED visit. Excluding such patients may have skewed the results from the real-world setting, which would make the model idealistic but less practical. In the subgroup analysis in which the patients to whom antibiotics were prescribed before the ED visit were eliminated, the number of patients in each risk-stratified group was similar with that of the entire cohort, and the true bacteremia rate was 2.9% that was not significantly different from the overall study population (p = 0.695; Table S6 ).
Additionally, there were interhospital discrepancies in the number of admitted patients when the annual ED census of each hospital was considered. We might not have included all the CAP patients admitted via the ED because we extracted the patient data only using ICD-9 diagnosis codes. If some patients were admitted to a ward due to CAP, and the diagnosis at the time of hospitalization was not CAP but the patient's comorbidity, these patients may not have been included in the data extraction step. Additionally, discrepancies in hospitalization criteria and the collection rate of blood cultures could have contributed to selection bias.
Finally, some laboratory parameters used in the prediction model would be an obstacle for wide implementation of the model. Time taken for reporting of CRP or albumin results could delay rapid decision making for blood culture and some institutes might not routinely use those parameters as initial laboratory tests of CAP patients. However, excluding those laboratory parameters lowered sensitivity of the model which was strength of our study compared with previous studies. 6, 11 
CONCLUSIONS
In this multicenter external validation study, we found that the previous bacteremia prediction model was well validated in the general population and could help physicians make the decision to reduce the number of blood cultures in patients with community-acquired pneumonia. Further prospective studies should be performed to demonstrate that implementation of this scoring system can reduce the number of blood cultures without any changes in clinical outcomes.
